ES2230711T3 - Combinaciones de progestinas de conservacion endometrial y progestinas de atrofia endometrial con estrogenos, en anticoncepcion oral. - Google Patents

Combinaciones de progestinas de conservacion endometrial y progestinas de atrofia endometrial con estrogenos, en anticoncepcion oral.

Info

Publication number
ES2230711T3
ES2230711T3 ES98942166T ES98942166T ES2230711T3 ES 2230711 T3 ES2230711 T3 ES 2230711T3 ES 98942166 T ES98942166 T ES 98942166T ES 98942166 T ES98942166 T ES 98942166T ES 2230711 T3 ES2230711 T3 ES 2230711T3
Authority
ES
Spain
Prior art keywords
daily
progestin
dose
doses
esp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98942166T
Other languages
English (en)
Spanish (es)
Inventor
Michael Kafrissen
Haya Taitel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Application granted granted Critical
Publication of ES2230711T3 publication Critical patent/ES2230711T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
ES98942166T 1997-08-27 1998-08-20 Combinaciones de progestinas de conservacion endometrial y progestinas de atrofia endometrial con estrogenos, en anticoncepcion oral. Expired - Lifetime ES2230711T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5710997P 1997-08-27 1997-08-27
US57109P 1997-08-27

Publications (1)

Publication Number Publication Date
ES2230711T3 true ES2230711T3 (es) 2005-05-01

Family

ID=22008560

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98942166T Expired - Lifetime ES2230711T3 (es) 1997-08-27 1998-08-20 Combinaciones de progestinas de conservacion endometrial y progestinas de atrofia endometrial con estrogenos, en anticoncepcion oral.

Country Status (9)

Country Link
EP (1) EP1007052B1 (cg-RX-API-DMAC7.html)
JP (1) JP2001513566A (cg-RX-API-DMAC7.html)
AT (1) ATE279198T1 (cg-RX-API-DMAC7.html)
AU (1) AU9028098A (cg-RX-API-DMAC7.html)
DE (1) DE69827017T2 (cg-RX-API-DMAC7.html)
DK (1) DK1007052T3 (cg-RX-API-DMAC7.html)
ES (1) ES2230711T3 (cg-RX-API-DMAC7.html)
PT (1) PT1007052E (cg-RX-API-DMAC7.html)
WO (1) WO1999009993A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030355A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
US7772219B2 (en) * 2003-05-02 2010-08-10 Teva Women's Health, Inc. Methods of hormonal treatment utilizing extended cycle contraceptive regimens
CA2771944A1 (en) * 2003-07-16 2005-01-27 Teva Women's Health, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
AU2004277998A1 (en) * 2003-10-01 2005-04-14 Janssen Pharmaceutica N.V. Extended triphasic contraceptive regimens
EP1535618A1 (en) 2003-11-26 2005-06-01 Schering Aktiengesellschaft Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) * 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4616006A (en) * 1983-09-26 1986-10-07 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
DK174724B1 (da) * 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
FI101601B (fi) * 1987-09-24 1998-07-31 Jencap Res Ltd Ehkäisyvalmiste sekä estrogeenin ja progestiinin käyttö ehkäisyvalmist een valmistusmenetelmässä
DE4104385C1 (cg-RX-API-DMAC7.html) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich

Also Published As

Publication number Publication date
DE69827017T2 (de) 2006-03-09
AU9028098A (en) 1999-03-16
DE69827017D1 (de) 2004-11-18
EP1007052B1 (en) 2004-10-13
WO1999009993A1 (en) 1999-03-04
PT1007052E (pt) 2005-01-31
DK1007052T3 (da) 2005-01-31
EP1007052A1 (en) 2000-06-14
ATE279198T1 (de) 2004-10-15
JP2001513566A (ja) 2001-09-04

Similar Documents

Publication Publication Date Title
US6797282B2 (en) Combination progestin oral contraceptive regimen
US8063030B2 (en) Extended cycle multiphasic oral contraceptive method
RU2245713C2 (ru) Прерывистая гормонозаместительная терапия низкими дозами эстрогена
EP0686037B1 (en) Hormone replacement therapy
US9132137B2 (en) Graduated estrogen contraceptive
US5521166A (en) Antiprogestin cyclophasic hormonal regimen
RU2122854C1 (ru) Комбинированный препарат для контрацепции, фармацевтическая упаковка для контрацепции
JPH04290828A (ja) 低エストロゲン経口避妊薬
JPH01132523A (ja) ホルモン製剤及び方法
US8461138B2 (en) Quadraphasis continuous graduated estrogen contraceptive
ES2229378T3 (es) Anticonceptivo oral.
AU759925B2 (en) Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin
EP1007052B1 (en) Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception
ES2397983T3 (es) Procedimiento anticonceptivo oral multifásico de ciclo prolongado
US20030176404A1 (en) Progestogen-anti-progestogen regimens
NZ234210A (en) Composition comprising melatonin and an androgen
JPH11501649A (ja) 閉経周辺期及び閉経前期にある女性に対する徐放性避妊薬としての及びホルモン補充療法に使用する1月用注射薬
MXPA00004610A (en) Progestogen-antiprogestogen regimens
MXPA97004742A (es) Compuestos con propiedades antagonistas de progesterona y anti-estrogeno para su uso combinado en la anticoncepcion femenina
MXPA06009740A (en) Extended cycle multiphasic oral contraceptive method
MXPA99000883A (en) Oral contraceptive